CA2279233A1 - Arginine silicate complex and use thereof - Google Patents

Arginine silicate complex and use thereof Download PDF

Info

Publication number
CA2279233A1
CA2279233A1 CA002279233A CA2279233A CA2279233A1 CA 2279233 A1 CA2279233 A1 CA 2279233A1 CA 002279233 A CA002279233 A CA 002279233A CA 2279233 A CA2279233 A CA 2279233A CA 2279233 A1 CA2279233 A1 CA 2279233A1
Authority
CA
Canada
Prior art keywords
complex
arginine
silicate
bone
individual
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002279233A
Other languages
English (en)
French (fr)
Inventor
Mark F. Mccarty
Jan Zielinski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nutrition 21 LLC
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2279233A1 publication Critical patent/CA2279233A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/695—Silicon compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/04—Esters of silicic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CA002279233A 1997-02-12 1998-02-11 Arginine silicate complex and use thereof Abandoned CA2279233A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/799,784 1997-02-12
US08/799,784 US5707970A (en) 1997-02-12 1997-02-12 Arginine silicate complex and use thereof
PCT/US1998/002443 WO1998034647A1 (en) 1997-02-12 1998-02-11 Arginine silicate inositol complex and use thereof

Publications (1)

Publication Number Publication Date
CA2279233A1 true CA2279233A1 (en) 1998-08-13

Family

ID=25176739

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002279233A Abandoned CA2279233A1 (en) 1997-02-12 1998-02-11 Arginine silicate complex and use thereof

Country Status (16)

Country Link
US (3) US5707970A (https=)
EP (1) EP1007096B1 (https=)
JP (1) JP2001512443A (https=)
KR (1) KR20000070977A (https=)
CN (1) CN1182873C (https=)
AT (1) ATE251914T1 (https=)
AU (1) AU722975B2 (https=)
BR (1) BR9807675A (https=)
CA (1) CA2279233A1 (https=)
DE (1) DE69819016T2 (https=)
DK (1) DK1007096T3 (https=)
ES (1) ES2209112T3 (https=)
HU (1) HUP0001998A3 (https=)
IL (1) IL130925A0 (https=)
PT (1) PT1007096E (https=)
WO (1) WO1998034647A1 (https=)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5707970A (en) * 1997-02-12 1998-01-13 Nutrition 21 Arginine silicate complex and use thereof
US20020068365A1 (en) * 1998-07-28 2002-06-06 Eric H. Kuhrts Controlled release nitric oxide producing agents
WO2002008175A2 (en) * 2000-07-24 2002-01-31 Nutrition 21, Inc. Arginine saccharate and use thereof
US6552074B2 (en) * 2000-11-16 2003-04-22 Fukumi Morishige Arginine/ascorbic acid mixed powder as an oral supplement
TWI283427B (en) * 2001-07-12 2007-07-01 Semiconductor Energy Lab Display device using electron source elements and method of driving same
AU2002360765C1 (en) * 2001-12-20 2009-06-11 Trivascular, Inc. Advanced endovascular graft
US7147661B2 (en) * 2001-12-20 2006-12-12 Boston Scientific Santa Rosa Corp. Radially expandable stent
US20040097467A1 (en) * 2002-08-22 2004-05-20 Vijaya Juturu Arginine silicate inositol complex and use thereof
US6803456B1 (en) * 2003-08-13 2004-10-12 Rutherford Chemicals Llc Process for the production of arginine-silicate complex
US7803178B2 (en) * 2004-01-30 2010-09-28 Trivascular, Inc. Inflatable porous implants and methods for drug delivery
CA2558573A1 (en) * 2004-03-11 2005-09-22 Trivascular, Inc. Modular endovascular graft
DE602005013244D1 (de) * 2004-08-12 2009-04-23 Quest Pharmaceutical Services Pharmazeutische zusammensetzungen für die kontroll
US7919620B2 (en) * 2005-06-01 2011-04-05 Coral Biotech Kabushiki Kaisha Agent for suppressing blood pressure elevation
ITMI20060677A1 (it) * 2006-04-06 2007-10-07 Damor Farmaceutici Profarmaci dell'arginina ad elevata attivita'terapeutica
EP2070541A4 (en) * 2006-09-21 2011-04-13 Toshiki Oguro MEANS FOR PROMOTING REGENERATION OF HARD FABRIC
EP3050568B1 (en) 2007-03-13 2020-12-02 JDS Therapeutics, LLC Methods and compositions for the sustained release of chromium
WO2009002867A2 (en) 2007-06-26 2008-12-31 Nutrition 21, Inc. Multiple unit dosage form having a therapeutic agents in combination with a nutritional supplement
GB0805279D0 (en) * 2008-03-20 2008-04-30 Univ Nottingham Trent Food supplement
WO2012035364A1 (en) 2010-09-15 2012-03-22 Creogen D.O.O. Stabilized solution of ortho-silicic acid, its preparation and use
EP4070801A1 (en) 2011-03-01 2022-10-12 Nutrition 21, LLC Compositions of insulin and chromium for the treatment and prevention of diabetes, hypoglycemia and related disorders
US11191735B2 (en) 2015-03-13 2021-12-07 Nutrition 21, Llc Arginine silicate for periodontal disease
ES2797688T3 (es) * 2015-06-30 2020-12-03 Nutrition 21 Llc Arginina silicato inositol para mejorar la función cognitiva
EP3322661B1 (en) 2015-07-13 2022-03-02 Otis Elevator Company Deterrent device inhibition key
US20170135969A1 (en) 2015-11-12 2017-05-18 Jds Therapeutics, Llc Topical arginine-silicate-inositol for wound healing
CA3014308A1 (en) 2016-02-11 2017-08-17 Nutrition 21, Llc Chromium containing compositions for improving health and fitness
GB2568849B (en) 2016-09-01 2022-08-10 Nutrition 21 Llc Magnesium biotinate compositions and methods of use
JP2022515314A (ja) * 2018-11-02 2022-02-18 ニュートリション・２１，エルエルシー イノシトール安定化アルギニンケイ酸塩複合体及びイノシトールを含有するビデオゲームプレーヤーの認知機能を改善するための組成物
GB2613672A (en) 2019-12-16 2023-06-14 Nutrition 21 Llc Methods of production of aginine-silicate complexes
CA3237984A1 (en) * 2021-11-12 2023-05-19 Nutrition21, LLC Compositions and methods for treating or preventing myopathy in poultry
CN118206406B (zh) * 2024-03-20 2025-08-15 山东农业大学 精氨酸硅酸盐肌醇络合物在提高作物果实品质中的应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3337403A (en) * 1963-09-05 1967-08-22 Hoffmann La Roche Stable and palatable pharmaceutical compositions
US4297349A (en) * 1980-04-15 1981-10-27 Sandoz, Inc. Silicon-bearing carboxylic acids and amides
US4385052A (en) * 1981-07-20 1983-05-24 International Plant Research Institute, Inc. Use of trialkylsilyl-6-aminonicotinamides for the treatment of psoriasis
FR2610522B1 (fr) * 1987-02-06 1989-08-18 Gueyne Jean Produit therapeutique a base de derives organiques du silicium
US5250569A (en) * 1991-04-22 1993-10-05 Godfrey Science & Design, Inc. Amino acid flavorings of aluminum astringent for oral use
US5622980A (en) * 1993-08-17 1997-04-22 Applied Analytical Industries, Inc. Oral compositions of H2-antagonists
FR2745498A1 (fr) * 1996-02-29 1997-09-05 Giroux Jean Marc Composition pur augmenter conjointement la tolerance biologique et l'efficacite amincissante des produits hyperproteines hypocaloriques destines au traitement de l'obesite
US5707970A (en) * 1997-02-12 1998-01-13 Nutrition 21 Arginine silicate complex and use thereof

Also Published As

Publication number Publication date
BR9807675A (pt) 2000-02-15
EP1007096B1 (en) 2003-10-15
CN1246801A (zh) 2000-03-08
US5707970A (en) 1998-01-13
IL130925A0 (en) 2001-01-28
DE69819016T2 (de) 2004-04-29
ES2209112T3 (es) 2004-06-16
HUP0001998A3 (en) 2002-01-28
JP2001512443A (ja) 2001-08-21
US6344444B1 (en) 2002-02-05
PT1007096E (pt) 2004-03-31
AU722975B2 (en) 2000-08-17
KR20000070977A (ko) 2000-11-25
DK1007096T3 (da) 2003-12-01
EP1007096A1 (en) 2000-06-14
CN1182873C (zh) 2005-01-05
DE69819016D1 (de) 2003-11-20
HUP0001998A2 (hu) 2000-10-28
ATE251914T1 (de) 2003-11-15
WO1998034647A1 (en) 1998-08-13
AU6273798A (en) 1998-08-26
US6156735A (en) 2000-12-05

Similar Documents

Publication Publication Date Title
AU722975B2 (en) Arginine silicate inositol complex and use thereof
JP2528115B2 (ja) イノシト−ルトリホスフエ−トを含有する医薬組成物
AU717533B2 (en) Magnesium (-)hydroxycitrate, preparation process, uses and compositions, in particular pharmaceutical compositions, containing it
US4732998A (en) Bisphosphonic acids and esters
JPH08505141A (ja) コレステロール生合成阻害剤およびβ−ラクタムコレステロール吸収阻害剤の組合せ
JPH07502263A (ja) 有機ホウ素化合物を利用して、動物の骨粗鬆症及びその他の病気を治療する方法
FR2499408A1 (fr) Composition pharmaceutique pour le traitement de l'osteopathie, a base d'acide 6-amino-1-hydroxyhexane-1,1-diphosphonique
CA1337928C (en) Topically applied gold organic complex
MXPA99007232A (en) Arginine silicate inositol complex and use thereof
US6169083B1 (en) Preventives/remedies for stomatitis
EP0443028A1 (en) Non-injection carcinostatic agent for suppressing occurrence of inflammation due to 5-fluorouracil and method for curing cancer
CZ278799A3 (cs) Arginin-silikát-inositolový komplex a jeho použití
AU634307B2 (en) Orally administered porphyrins to control intestinal iron absorption
US4000265A (en) Method for treating arteriosclerotic and cardiovascular disorders
US4336251A (en) Medicaments containing an organosilicon compound
JPS61145116A (ja) オステオポロ−ジス治療剤
NL7902233A (nl) Werkwijze voor het bereiden van een geneesmiddel voor het behandelen van niet-neoplastische obstructieve icterus.
CA2259997C (en) Remedies and preventives for stomatitis
JPH0541606B2 (https=)
JPS6150963A (ja) グルタチオンおよびアミノメルカプトカルボン酸類のｓ−（カルバモイル−フエニルセレニル）誘導体ならびにそれらの製法
LU85865A1 (fr) Nouveaux derives du pyrane,leur preparation et compositions therapeutiques en contenant
WO2002008175A2 (en) Arginine saccharate and use thereof

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued